• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

标准护理联合静脉溶栓与不联合静脉溶栓治疗轻度缺血性卒中的比较疗效

Comparative effectiveness of standard care with IV thrombolysis versus without IV thrombolysis for mild ischemic stroke.

作者信息

Choi Jay Chol, Jang Min Uk, Kang Kyusik, Park Jong-Moo, Ko Youngchai, Lee Soo-Joo, Cha Jae-Kwan, Kim Dae-Hyun, Park Sang Soon, Park Tai Hwan, Lee Kyung Bok, Lee Jun, Kim Joon-Tae, Cho Ki-Hyun, Yu Kyung-Ho, Oh Mi-Sun, Lee Byung-Chul, Cho Yong-Jin, Kim Dong-Eog, Lee Ji Sung, Lee Juneyoung, Gorelick Philip B, Bae Hee-Joon

出版信息

J Am Heart Assoc. 2015 Jan 27;4(1):e001306. doi: 10.1161/JAHA.114.000596.

DOI:10.1161/JAHA.114.000596
PMID:25628404
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4330057/
Abstract

BACKGROUND

One third of patients presenting with initially mild strokes have unfavorable outcomes, and the efficacy of intravenous thrombolysis (IVT) in this population has not been proven. This study aimed to evaluate the comparative effectiveness of standard care with IVT versus without IVT in mild stroke patients.

METHODS AND RESULTS

Using a multicenter stroke registry database, we identified patients with acute ischemic stroke who presented within 4.5 hours of symptom onset and had initial National Institutes of Health Stroke Scale scores ≤5. Multivariable logistic analysis and propensity score matching were used to adjust for baseline imbalances between the patients who did and did not receive IVT. Adjusted odds ratios and 95% CIs of IVT were estimated for 3-month modified Rankin Scale scores of 0 to 1 and symptomatic. Of 13 117 patients with stroke who were hospitalized between April 2008 and May 2012, 1386 met the eligibility criteria, and 194 (14.0%) were treated with IVT. For a modified Rankin Scale of 0 to 1 at 3 months, the adjusted odds ratios were 1.96 (95% CI, 1.28 to 3.00; P=0.002) by multivariable logistic analysis and 1.68 (1.10 to 2.56; P=0.02) by propensity score matching analysis, respectively. There was a statistically nonsignificant excess of symptomatic hemorrhagic transformation (odds ratios=3.76 [0.95 to 16.42; P=0.06] and 4.81 [0.84 to 49.34; P=0.09]), respectively.

CONCLUSIONS

In this observational registry-based study, standard care with IVT is more effective than not receiving IVT in mildischemic stroke patients, and there is a statistically nonsignificant risk of symptomatic hemorrhagic transformation.

摘要

背景

最初表现为轻度卒中的患者中有三分之一预后不佳,而静脉溶栓(IVT)在这一人群中的疗效尚未得到证实。本研究旨在评估轻度卒中患者接受IVT标准治疗与未接受IVT标准治疗的相对有效性。

方法与结果

利用多中心卒中登记数据库,我们识别出症状发作4.5小时内就诊且初始美国国立卫生研究院卒中量表评分≤5分的急性缺血性卒中患者。采用多变量逻辑分析和倾向评分匹配来调整接受和未接受IVT患者之间的基线不平衡。估计IVT的调整比值比和95%置信区间用于3个月改良Rankin量表评分为0至1分且有症状的情况。在2008年4月至2012年5月期间住院的13117例卒中患者中,1386例符合纳入标准,194例(14.0%)接受了IVT治疗。对于3个月时改良Rankin量表评分为0至1分,多变量逻辑分析的调整比值比为1.96(95%置信区间,1.28至3.00;P = 0.002),倾向评分匹配分析的调整比值比为1.68(1.10至2.56;P = 0.02)。症状性出血转化分别有统计学上无显著意义的增加(比值比分别为3.76 [0.95至16.42;P = 0.06]和4.81 [0.84至49.34;P = 0.09])。

结论

在这项基于观察性登记的研究中,对于轻度缺血性卒中患者,接受IVT标准治疗比未接受IVT更有效,且症状性出血转化风险在统计学上无显著意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6b1/4330057/aaff0f0c3d1f/jah3-4-e001306-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6b1/4330057/27967b80a2d9/jah3-4-e001306-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6b1/4330057/48fc53259fd3/jah3-4-e001306-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6b1/4330057/aaff0f0c3d1f/jah3-4-e001306-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6b1/4330057/27967b80a2d9/jah3-4-e001306-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6b1/4330057/48fc53259fd3/jah3-4-e001306-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6b1/4330057/aaff0f0c3d1f/jah3-4-e001306-g3.jpg

相似文献

1
Comparative effectiveness of standard care with IV thrombolysis versus without IV thrombolysis for mild ischemic stroke.标准护理联合静脉溶栓与不联合静脉溶栓治疗轻度缺血性卒中的比较疗效
J Am Heart Assoc. 2015 Jan 27;4(1):e001306. doi: 10.1161/JAHA.114.000596.
2
Preceding Intravenous Thrombolysis in Patients Receiving Endovascular Therapy.接受血管内治疗患者的静脉溶栓前情况
Cerebrovasc Dis. 2017;44(1-2):51-58. doi: 10.1159/000471492. Epub 2017 Apr 21.
3
Does renal dysfunction modify the effect of intravenous thrombolysis for acute ischemic stroke within 4.5 hours of onset? A multicenter observational study.肾功能不全是否会改变急性缺血性卒中发病4.5小时内静脉溶栓的效果?一项多中心观察性研究。
J Stroke Cerebrovasc Dis. 2015 Mar;24(3):673-9. doi: 10.1016/j.jstrokecerebrovasdis.2014.11.006. Epub 2015 Jan 7.
4
Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.急性缺血性卒中中联合静脉和动脉溶栓与使用重组组织型纤溶酶原激活剂进行原发性动脉治疗的比较。
J Stroke Cerebrovasc Dis. 2008 May-Jun;17(3):121-8. doi: 10.1016/j.jstrokecerebrovasdis.2007.12.004.
5
Influence of arterial occlusion on outcome after intravenous thrombolysis for acute ischemic stroke.动脉闭塞对急性缺血性脑卒中静脉溶栓治疗后结局的影响。
Stroke. 2015 Jan;46(1):126-31. doi: 10.1161/STROKEAHA.114.006408. Epub 2014 Nov 25.
6
Editor's choice - Safety of carotid endarterectomy after intravenous thrombolysis for acute ischaemic stroke: a case-controlled multicentre registry study.编辑精选 - 急性缺血性脑卒中静脉溶栓后颈动脉内膜切除术的安全性:一项病例对照多中心登记研究。
Eur J Vasc Endovasc Surg. 2014 Dec;48(6):620-5. doi: 10.1016/j.ejvs.2014.09.004. Epub 2014 Oct 16.
7
Platelet-to-White Blood Cell Ratio: A Prognostic Predictor for 90-Day Outcomes in Ischemic Stroke Patients with Intravenous Thrombolysis.血小板与白细胞比值:静脉溶栓治疗的缺血性中风患者90天预后的预测指标
J Stroke Cerebrovasc Dis. 2016 Oct;25(10):2430-8. doi: 10.1016/j.jstrokecerebrovasdis.2016.06.015. Epub 2016 Jun 29.
8
Aphasia predicts unfavorable outcome in mild ischemic stroke patients and prompts thrombolytic treatment.失语症预测轻度缺血性中风患者的不良预后,并促使溶栓治疗。
J Stroke Cerebrovasc Dis. 2014 Feb;23(2):204-8. doi: 10.1016/j.jstrokecerebrovasdis.2012.11.018. Epub 2013 Jan 24.
9
Safety of Statin Pretreatment in Intravenous Thrombolysis for Acute Ischemic Stroke.他汀类药物预处理在急性缺血性脑卒中静脉溶栓治疗中的安全性
Stroke. 2015 Sep;46(9):2681-4. doi: 10.1161/STROKEAHA.115.010244. Epub 2015 Jul 14.
10
Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.FLAIR 高信号病灶作为影像生物标志物预测静脉溶栓后动脉内溶栓治疗急性卒中的结局
Cerebrovasc Dis. 2013;35(5):461-8. doi: 10.1159/000350201. Epub 2013 May 31.

引用本文的文献

1
Effectiveness and Limitations of Intravenous rt-PA Therapy in Patients with Mild Cerebral Infarction.静脉注射重组组织型纤溶酶原激活剂治疗轻度脑梗死患者的有效性及局限性
J Atheroscler Thromb. 2025 Jun 1;32(6):661-669. doi: 10.5551/jat.RV22034. Epub 2025 Mar 26.
2
A study of the safety and efficacy of multi-mode NMR-guided double-antiplatelet pretreatment combined with low-dose rtPA in the treatment of acute mild ischemic stroke.多模式核磁共振引导下双重抗血小板预处理联合低剂量重组组织型纤溶酶原激活剂治疗急性轻度缺血性卒中的安全性和有效性研究
Front Neurol. 2025 Mar 5;16:1482078. doi: 10.3389/fneur.2025.1482078. eCollection 2025.
3

本文引用的文献

1
MRI-based Algorithm for Acute Ischemic Stroke Subtype Classification.基于 MRI 的急性缺血性脑卒中亚型分类算法。
J Stroke. 2014 Sep;16(3):161-72. doi: 10.5853/jos.2014.16.3.161. Epub 2014 Sep 30.
2
Mild stroke: safety and outcome in patients receiving thrombolysis.轻度中风:接受溶栓治疗患者的安全性及预后
Acta Neurol Scand Suppl. 2014(198):37-40. doi: 10.1111/ane.12235.
3
Thrombolysis in patients with mild stroke: results from the Austrian Stroke Unit Registry.轻度卒中患者的溶栓治疗:来自奥地利卒中单元登记研究的结果。
Prevalence and outcomes of mild stroke patients undergoing reperfusion therapy: A meta-analysis and SAFE recommendations for optimal management.
接受再灌注治疗的轻度中风患者的患病率及预后:一项荟萃分析及关于最佳管理的SAFE建议
J Cent Nerv Syst Dis. 2025 Feb 12;17:11795735251314881. doi: 10.1177/11795735251314881. eCollection 2025.
4
Safety and efficacy of intravenous thrombolysis: a systematic review and meta-analysis of 93,057 minor stroke patients.静脉溶栓的安全性和有效性:对93057例轻度中风患者的系统评价和荟萃分析。
BMC Neurol. 2025 Jan 22;25(1):33. doi: 10.1186/s12883-024-04000-8.
5
Acute treatment and secondary prevention for patients with minor stroke or transient ischemic attack: A Bayesian network meta-analysis.轻度卒中或短暂性脑缺血发作患者的急性治疗与二级预防:一项贝叶斯网络荟萃分析。
Eur Stroke J. 2024 Nov 29:23969873241303686. doi: 10.1177/23969873241303686.
6
Antiplatelet therapy versus intravenous thrombolysis for mild acute ischaemic stroke: a living systematic review and meta-analysis.抗血小板治疗与静脉溶栓治疗轻度急性缺血性卒中的比较:一项实时系统评价和荟萃分析。
Stroke Vasc Neurol. 2025 Apr 29;10(2):e003097. doi: 10.1136/svn-2024-003097.
7
Combining Intravenous Thrombolysis and Dual Antiplatelet Treatment in Patients With Minor Ischemic Stroke: A Propensity Matched Analysis of the READAPT Study Cohort.联合静脉溶栓和双联抗血小板治疗对轻型缺血性卒中患者的影响:READAPT 研究队列的倾向性匹配分析。
J Am Heart Assoc. 2024 Aug 20;13(16):e036275. doi: 10.1161/JAHA.124.036275. Epub 2024 Aug 9.
8
Intravenous thrombolysis versus dual antiplatelet therapy for patients with acute minor ischaemic stroke: a systematic review and meta-analysis.急性轻度缺血性中风患者静脉溶栓与双重抗血小板治疗的系统评价和荟萃分析
Front Pharmacol. 2024 Jun 10;15:1377475. doi: 10.3389/fphar.2024.1377475. eCollection 2024.
9
Software with artificial intelligence-derived algorithms for analysing CT brain scans in people with a suspected acute stroke: a systematic review and cost-effectiveness analysis.软件采用人工智能衍生算法分析疑似急性脑卒中患者的 CT 脑扫描:系统评价和成本效益分析。
Health Technol Assess. 2024 Mar;28(11):1-204. doi: 10.3310/RDPA1487.
10
Rationale and design of ProUrokinase in Mild IsChemic strokE (PUMICE): a multicentre, prospective, randomised, open-label, blinded-endpoint controlled trial.尿激酶原治疗轻度缺血性卒中(PUMICE)的原理与设计:一项多中心、前瞻性、随机、开放标签、终点设盲的对照试验。
Stroke Vasc Neurol. 2024 Dec 30;9(6):715-722. doi: 10.1136/svn-2023-002673.
Stroke. 2014 Mar;45(3):765-9. doi: 10.1161/STROKEAHA.113.003827. Epub 2014 Jan 30.
4
Current status of acute stroke management in Korea: a report on a multicenter, comprehensive acute stroke registry.韩国急性卒中管理的现状:一项关于多中心、综合性急性卒中登记的报告。
Int J Stroke. 2014 Jun;9(4):514-8. doi: 10.1111/ijs.12199. Epub 2013 Nov 21.
5
Review, historical context, and clarifications of the NINDS rt-PA stroke trials exclusion criteria: Part 1: rapidly improving stroke symptoms.NINDS rt-PA 卒中试验排除标准的回顾、历史背景和澄清:第 1 部分:症状迅速改善的卒中。
Stroke. 2013 Sep;44(9):2500-5. doi: 10.1161/STROKEAHA.113.000878. Epub 2013 Jul 11.
6
Validation of minor stroke definitions for thrombolysis decision making.验证用于溶栓决策的小卒中定义。
J Stroke Cerebrovasc Dis. 2013 May;22(4):482-90. doi: 10.1016/j.jstrokecerebrovasdis.2013.03.006. Epub 2013 Mar 30.
7
The outcome of patients with mild stroke improves after treatment with systemic thrombolysis.轻度中风患者在接受全身溶栓治疗后,其预后得到改善。
PLoS One. 2013;8(3):e59420. doi: 10.1371/journal.pone.0059420. Epub 2013 Mar 19.
8
Thrombolysis in stroke despite contraindications or warnings?溶栓治疗脑卒中,禁忌证和警告是否需要考虑?
Stroke. 2013 Mar;44(3):727-33. doi: 10.1161/STROKEAHA.112.674622. Epub 2013 Feb 6.
9
Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.急性缺血性脑卒中患者早期管理指南:美国心脏协会/美国卒中协会医疗保健专业人员指南。
Stroke. 2013 Mar;44(3):870-947. doi: 10.1161/STR.0b013e318284056a. Epub 2013 Jan 31.
10
Mechanism of medullary infarction based on arterial territory involvement.基于动脉供血区域的脑桥梗死的发病机制。
J Clin Neurol. 2012 Jun;8(2):116-22. doi: 10.3988/jcn.2012.8.2.116. Epub 2012 Jun 29.